Study of Psychiatric Comorbidities in Patients With Bronchial Asthma
Introduction: Patients with asthma tend to have anxiety and depression. The presence of psychological morbidity is, however, frequently underestimated, so under diagnosed and under treated.
Objective: To evaluate some psychiatric comorbidities (depression and anxiety) in asthmatic patient and to examine the possible associations with the demographic and clinical characteristics as well as the level of control of asthma in those patients.
Methods: One hundred asthmatic patients were enrolled in this study. The level of control was assessed by Asthma Control Questionnaire (ACQ), Anxiety was assessed by The Generalized Anxiety Disorder Scale (GADS). Depression was assessed by The Hamilton Depression Rating Scale (HAM-D). RESULTS: The prevalence of anxiety was significantly higher among patients with uncontrolled asthma especially moderate and severe anxiety (67.1% in poorly controlled asthma group and 11.1% in controlled asthma group but 8.5% in poorly controlled asthma group and 0.0 % in controlled asthma group respectively with p<0.001). Depression was significantly higher among patients with uncontrolled asthma especially mild and moderate depression. (52.4% in poorly controlled asthma group and 11.1% in controlled group but 24.4% in poorly controlled group and 0.0 % in controlled asthma group respectively with p<0.001).
Conclusion: Anxiety and depression adversely affect asthma control and quality of life, raising the possibility that treating these psychological comorbidities could improve asthma control and quality of life.